Your question has been received!
One of our consultants will email you shortly.

Explore the pages below to learn more about
NGS testing for NSCLC patients

[Webinar recording] Endeavor to leave no patient behind: NGS in routine NSCLC biomarker testing

This CAP TODAY webinar explains how to make NSCLC biomarker testing a routine part of your care process. Using CGI case studies, you'll discover how to practice precision oncology in a way that ensures even challenging samples get tested, so you can achieve the best outcome for as many patients as possible. => Watch the Webinar

[Video] 2018 lung cancer guidelines update for clinicians by the CAP-IASLC-AMP

A lot has changed since the CAP, IASLC, and AMP shared their 2013 guidelines for NSCLC. To help you put the latest technology into clinical practice, they've created an “Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors." These new guidelines continue to set evidence-based standards for clinical molecular testing of non-small cell lung cancers to guide treatment decisions. => Watch the Video